Akèy › Maladi Alzheimer › Massachusetts › Newton
Etid klinik pou Maladi Alzheimer nan Newton, MA
12 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Newton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Ap rekriteFaz 3
- Boston Center for Memory, Newton
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Ap rekriteFaz 4
- Adams Clinical - Watertown, Watertown · 3 mi lwen
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Ap rekriteFaz 2
- Boston Center for Memory - Newton- Site Number : 8400007, Newton
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Ap rekriteFaz 2
- Adams Clinical Watertown, Watertown · 3 mi lwen
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Ap rekriteFaz 3
- Boston Center for Memory, Newton
- Adams Clinical Watertown, Watertown · 3 mi lwen
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Ap rekriteFaz 1/2
- Adams Clinical /ID# 277754, Watertown · 3 mi lwen
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Ap rekriteFaz 3
- Local Institution - 0080, Watertown · 3 mi lwen
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Ap rekriteFaz 3
- Boston Center for Memory, Newton
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Ap rekriteFaz 2
- Boston Center for Memory ( Site 1008), Newton
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Ap rekriteFaz 3
- Boston Center for Memory, Newton
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Ap rekriteFaz 3
- Boston Center for Memory, Newton
- MedVadis Research Corporation, Waltham · 3 mi lwen
Triage Survey for Neurology Research Eligibility
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Adams Clinical, Watertown · 3 mi lwen
Etid Maladi Alzheimer nan lòt vil
- Boston, MA26 etid
- Orlando, FL25 etid
- St. Louis, MO22 etid
- New York City, NY21 etid
- Miami, FL20 etid
- Tampa, FL17 etid
- Atlanta, GA16 etid
- Philadelphia, PA15 etid
- The Villages, FL15 etid
- Phoenix, AZ15 etid
- Indianapolis, IN14 etid
- Los Angeles, CA14 etid
Lòt etid nan Newton
- Twoub depresif majè10 etid
- Obèsite9 etid
- Depresyon7 etid
- Sipwa6 etid
- Psoryaz6 etid
- Kansè Poumon ki pa ti selil5 etid
- Doulè kwonik4 etid
- Kansè nan tete4 etid
- Skizofreni4 etid
- Fèbli Kognitif Lejè4 etid
- Dematit atopik (Ekzema)4 etid
- Kolit Ulseratif4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.